13G Filing: Palo Alto Investors and Alimera Sciences Inc (ALIM)
Please follow Palo Alto Investors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Palo Alto Investors or update its stock holdings...
Posts Tagged ‘Palo Alto Investors’
Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and Other Stocks Lift Its Q3 Returns
Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion.
Palo Alto’s Top Picks for This Year Following Impressive 2015 Returns
William Leland Edwards' Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management.
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States, with over $2 billion...
These Hot Healthcare Stocks Lead Palo Alto Investors’ Picks To Big Q2 Returns
William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of ...
Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)’s 18% Spike
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday's intraday trading to eventually close at 18% in the green at $72.48.
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Amicus Therapeutics, Inc. (FOLD): Redmile Group Trims Position and Books Some Profits from Long-Term Investment
Jeremy Green's Redmile Group has also reduced its stake in Amicus Therapeutics, Inc.
Amicus Therapeutics Inc. (FOLD): Palo Alto Investors Sells Half of its Stake At Sky-High Valuation
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD).
VIRGINIA NATL BNK (VABK), Alimera Sciences Inc (ALIM), Advanced Photonix, Inc. (API): Hedge Funds Disclose Moves In Their Equity Portfolios
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they have outlined potential ...
Hedge Fund News: Edward Lampert, George Soros & Bill Ackman
Hedge fund ESL Investments has loaned $400 million to its largest investment, Sears Holdings Corporation (NASDAQ:SHLD), a cash infusion that will keep the struggling retailer ...
Hedge Fund News: Phil Falcone, Louis Hanover & Bridgewater Associates
Minnesota Wild co-owner Phil Falcone might quit his hockey-crazed home state to make a play for the New York Islanders, The Post has learned.
InterMune Inc (ITMN), United Therapeutics Corporation (UTHR), Cyberonics Inc. (CYBX): Palo Alto Investors Loves Healthcare Stocks
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.
Perceptive Advisors Buys 4.0 Million Shares Of Amicus Therapeutics Inc. (FOLD)
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S.
Camber Capital Surges Stake In Sequenom Inc. (SQNM) To Over 5%
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM).
Consonance Capital Management is Fond of Healthcare Stocks
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Visium Asset Management’s Latest Purchase: AMAG Pharmaceuticals Inc. (AMAG)
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Samuel Isaly Says He Is Fond of Regeneron Pharmaceuticals Inc (REGN) & InterMune Inc (ITMN)
Samuel Isaly's Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on CNBC, Mr.
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Palo Alto Investors Sells Out Of Savient Pharmaceuticals
William Leland Edwards' fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ).
Hedge Fund Recruiters: Who Are They and What Do They Do?
There are hedge fund recruiters who take great pride in helping people find a job in the hedge fund industry.
How One Anacor Pharmaceuticals Insider is Making Bank
Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M.
Hedge Fund Career Advice: Getting Your Start
Since no two hedge fund jobs are the same, it goes without saying that your approach to applying for a position is not going to be identical to the next person.
This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)
Now, according to many investors, hedge funds are assumed to be overrated, outdated investment tools of an era lost to time.
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
ABIOMED, Inc. (ABMD): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the 21st century investor’s toolkit, there are tons of gauges investors can use to track the equity markets.
Hedge Funds Are Betting On Momenta Pharmaceuticals, Inc. (MNTA)
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Spectrum Pharmaceuticals, Inc. (SPPI): Are Hedge Funds Right About This Stock?
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
Do Hedge Funds and Insiders Love Sequenom, Inc. (SQNM)?
If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times.
QLT Inc. (USA) (QLTI): Are Hedge Funds Right About This Stock?
In the financial world, there are many indicators shareholders can use to analyze Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Should You Avoid Cyberonics, Inc. (CYBX)?
In today’s marketplace, there are a multitude of methods market participants can use to monitor the equity markets.
Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.
Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Auxilium Pharmaceuticals, Inc. (AUXL): Are Hedge Funds Right About This Stock?
To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times.
Is Questcor Pharmaceuticals Inc (QCOR) Going to Burn These Hedge Funds?
In today’s marketplace, there are a multitude of methods shareholders can use to watch stocks.
Do Hedge Funds and Insiders Love ArthroCare Corporation (ARTC)?
In the financial world, there are tons of metrics shareholders can use to analyze Mr. Market. A couple of the most innovative are hedge fund and insider trading sentiment.
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.
The Top 10 Hedge Funds: Can You Guess Who They Are?
The top hedge funds: there are many reasons why you may be seeking information related to the best performing money managers. Maybe you want to find a job in this field.
Hedge Fund Research: How Can You Learn From The World’s Richest Investors?
When it comes to hedge fund research, there used to be a time when getting your hands on the right information was a challenge.
What Are Hedge Funds?
Generally speaking, a hedge fund is an aggressively managed portfolio using advanced investment strategies – including leveraged, long, and short positions – as a means of...
This Metric Says You Are Smart to Sell STAAR Surgical Company (STAA)
STAAR Surgical Company (NASDAQ:STAA) was in 7 hedge funds' portfolio at the end of March.
Cytokinetics, Inc. (CYTK): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds' portfolio at the end of March.
Do Hedge Funds and Insiders Love AVEO Pharmaceuticals, Inc. (AVEO)?
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was in 9 hedge funds' portfolio at the end of the first quarter of 2013.
Should You Buy XOMA Corp (XOMA)?
In the eyes of most stock holders, hedge funds are seen as unimportant, old investment vehicles of yesteryear.
